Why Ozempic, Wegovy costs are higher in U.S. vs. other nations

Senators grilled Novo Nordisk CEO Lars Jrgensen Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight loss drugs, requesting explanations for why the U.S. faces a higher list price than other countries. MORE: https://abc7.com/ozempic-producer-ceo-in-hot-seat-in-congressional-hearing/15349111/